It was found through preliminary research that treatment with AOD9604 over the course of 14 days in obese mice led to decreased body weight and body fat and was shown to increase the activity of the beta(3)-adrenergic receptors in the fat cells to the same level as those in lean mice
See the KLOW vs GLOW vs Wolverine comparison and the KLOW dosage guide
Before starting therapy, we run comprehensive functional lab tests to identify the true cause of your symptoms
In the harsh, inflammatory environment of a fresh wound, many healing cells die off before they can finish their job
It is a prescribed compounded medication that needs a provider intake, dose titration, and follow-up, exactly like any other clinical prescription
Lipogenesis Inhibition Beyond breaking down existing fat, AOD-9604 also inhibits the formation of new fat cells